Clinical Trial Enrollment Intelligence
End-to-end enrollment dashboards, weekly newsletters, and patient level intelligence for biotech teams running Phase 1-3 clinical trials — designed, implemented in partnership, and transitioned to your team.
Site activation updates live in spreadsheets. Screen fail trends go untracked. Enrollment projections are rebuilt manually every week. The result is noise when leadership needs signal.
DATAlchemist was founded by Phoebe Nobes, a clinical data specialist with experience designing and implementing enrollment infrastructure across Phase 2 and 3 trials at Adverum Biotechnologies, Allakos Biotechnologies, and Retina Consultants of America.
Designed and refined through real studies — from the first line of code to the Friday evening newsletter landing in a CEO's inbox.
Schedule a 30-minute intro call.
[email protected]